Nanjing Leads Biolabs Co., Ltd. (HKG:9887)
Hong Kong · Delayed Price · Currency is HKD 51.25
-1.25 (-2.38%)
Jan 21, 2026, 4:08 PM HKT
Nanjing Leads Biolabs Market Cap
Nanjing Leads Biolabs has a market cap or net worth of 10.44 billion as of January 21, 2026.
Market Cap
10.44B
Enterprise Value
10.28B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
51.25
Market Cap Chart
Since July 25, 2025, Nanjing Leads Biolabs's market cap has decreased from 12.97B to 10.44B, a decrease of -19.52%. That is a compound annual growth rate of -35.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 10.44B | 2.94% |
| Dec 31, 2025 | 10.14B | -21.82% |
| Jul 25, 2025 | 12.97B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Everest Medicines | 13.55B |
| Ascletis Pharma | 13.39B |
| Mirxes Holding Company | 11.61B |
| HBM Holdings | 10.81B |
| Shanghai Haohai Biological Technology | 10.81B |
| Lepu Biopharma | 9.53B |
| Abbisko Cayman | 9.33B |
| Alphamab Oncology | 9.13B |